Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Aquestive Therapeutics Inc Share Price

AQST

NMQ

$3.65

-$0.1

(-2.67%)

Industry: Pharmaceuticals Sector: Health Care

Aquestive Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Aquestive Therapeutics Inc Share Price Chart

Aquestive Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$457.51M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

2.59M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.66

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$2.12 L

$7.55 H

$3.65

About Aquestive Therapeutics Inc, Common Stock

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Aquestive Therapeutics Inc Stock Returns

Time Frame	AQST	Sector	S&P500
1-Week Return	-8.76%	-1.08%	-1.38%
1-Month Return	9.65%	-0.47%	-1.81%
3-Month Return	-29.25%	2.13%	1.38%
6-Month Return	-6.48%	17.04%	5.68%
1-Year Return	8.07%	6.56%	11.74%
3-Year Return	346.43%	16.78%	65.15%
5-Year Return	-36.12%	34.34%	73.68%
10-Year Return	-76.64%	137.88%	260.03%

Time Frame	AQST	Sector	S&P500
1-Week Return	-99.16%	-43.23%	-51.55%
1-Month Return	206.74%	-5.57%	-19.93%
3-Month Return	-75.42%	8.92%	5.72%
6-Month Return	-12.70%	37.58%	11.85%
1-Year Return	8.07%	6.56%	11.74%
3-Year Return	64.66%	5.31%	18.20%
5-Year Return	-8.57%	6.08%	11.67%
10-Year Return	-13.53%	9.05%	13.67%

Aquestive Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	45.85M	50.83M	47.68M	50.58M	57.56M	[{"date":"2020-12-31","value":79.65,"profit":true},{"date":"2021-12-31","value":88.31,"profit":true},{"date":"2022-12-31","value":82.83,"profit":true},{"date":"2023-12-31","value":87.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	12.96M	14.99M	19.39M	20.83M	17.87M	[{"date":"2020-12-31","value":62.23,"profit":true},{"date":"2021-12-31","value":71.96,"profit":true},{"date":"2022-12-31","value":93.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.8,"profit":true}]
Gross Profit	32.88M	35.84M	28.29M	29.75M	39.69M	[{"date":"2020-12-31","value":82.86,"profit":true},{"date":"2021-12-31","value":90.31,"profit":true},{"date":"2022-12-31","value":71.29,"profit":true},{"date":"2023-12-31","value":74.96,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	71.72%	70.51%	59.34%	58.82%	68.95%	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.31,"profit":true},{"date":"2022-12-31","value":82.74,"profit":true},{"date":"2023-12-31","value":82.01,"profit":true},{"date":"2024-12-31","value":96.13,"profit":true}]

Operating Expenses	75.78M	70.52M	70.36M	44.85M	70.46M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.06,"profit":true},{"date":"2022-12-31","value":92.85,"profit":true},{"date":"2023-12-31","value":59.19,"profit":true},{"date":"2024-12-31","value":92.98,"profit":true}]
Operating Income	(42.89M)	(34.68M)	(42.07M)	(15.10M)	(30.77M)	[{"date":"2020-12-31","value":-4289300000,"profit":false},{"date":"2021-12-31","value":-3467900000,"profit":false},{"date":"2022-12-31","value":-4206600000,"profit":false},{"date":"2023-12-31","value":-1510200000,"profit":false},{"date":"2024-12-31","value":-3077100000,"profit":false}]
Total Non-Operating Income/Expense	(25.78M)	(57.90M)	(24.69M)	16.34M	(26.76M)	[{"date":"2020-12-31","value":-157.81,"profit":false},{"date":"2021-12-31","value":-354.42,"profit":false},{"date":"2022-12-31","value":-151.13,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-163.81,"profit":false}]
Pre-Tax Income	(55.78M)	(70.54M)	(54.41M)	(7.63M)	(44.15M)	[{"date":"2020-12-31","value":-5578300000,"profit":false},{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-762500000,"profit":false},{"date":"2024-12-31","value":-4415100000,"profit":false}]
Income Taxes	9.58M	19.50M	5.79M	245.00K	(14.00K)	[{"date":"2020-12-31","value":49.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":29.71,"profit":true},{"date":"2023-12-31","value":1.26,"profit":true},{"date":"2024-12-31","value":-0.07,"profit":false}]
Income After Taxes	(65.36M)	(90.04M)	(60.20M)	(7.87M)	(44.14M)	[{"date":"2020-12-31","value":-6536200000,"profit":false},{"date":"2021-12-31","value":-9003600000,"profit":false},{"date":"2022-12-31","value":-6020200000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false}]

Income From Continuous Operations	(55.78M)	(70.54M)	(54.41M)	(7.87M)	(44.14M)	[{"date":"2020-12-31","value":-5578300000,"profit":false},{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(55.78M)	(70.54M)	(54.41M)	(7.87M)	(44.14M)	[{"date":"2020-12-31","value":-5578300000,"profit":false},{"date":"2021-12-31","value":-7053900000,"profit":false},{"date":"2022-12-31","value":-5441000000,"profit":false},{"date":"2023-12-31","value":-787000000,"profit":false},{"date":"2024-12-31","value":-4413700000,"profit":false}]

EPS (Diluted)	(1.65)	(1.49)	(1.14)	(0.36)	(0.49)	[{"date":"2020-12-31","value":-165,"profit":false},{"date":"2021-12-31","value":-149,"profit":false},{"date":"2022-12-31","value":-114,"profit":false},{"date":"2023-12-31","value":-36,"profit":false},{"date":"2024-12-31","value":-49.07,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	10.87%	(6.20%)	6.09%	13.80%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":78.78,"profit":true},{"date":"2022-12-31","value":-44.95,"profit":false},{"date":"2023-12-31","value":44.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	15.62%	29.33%	7.45%	(14.20%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":53.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":25.41,"profit":true},{"date":"2024-12-31","value":-48.42,"profit":false}]
Gross Profit	-	8.99%	(21.06%)	5.15%	33.40%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":26.93,"profit":true},{"date":"2022-12-31","value":-63.06,"profit":false},{"date":"2023-12-31","value":15.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	(1.69%)	(15.84%)	(0.88%)	17.23%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9.81,"profit":false},{"date":"2022-12-31","value":-91.96,"profit":false},{"date":"2023-12-31","value":-5.12,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	-	(6.94%)	(0.23%)	(36.25%)	57.09%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-12.15,"profit":false},{"date":"2022-12-31","value":-0.4,"profit":false},{"date":"2023-12-31","value":-63.5,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	(19.15%)	21.30%	(64.10%)	103.75%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-18.46,"profit":false},{"date":"2022-12-31","value":20.53,"profit":true},{"date":"2023-12-31","value":-61.78,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	124.58%	(57.36%)	(166.17%)	(263.81%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-46.04,"profit":false},{"date":"2023-12-31","value":-133.38,"profit":false},{"date":"2024-12-31","value":-211.75,"profit":false}]
Pre-Tax Income	-	26.45%	(22.87%)	(85.99%)	479.03%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.52,"profit":true},{"date":"2022-12-31","value":-4.77,"profit":false},{"date":"2023-12-31","value":-17.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	103.54%	(70.29%)	(95.77%)	(105.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-67.89,"profit":false},{"date":"2023-12-31","value":-92.5,"profit":false},{"date":"2024-12-31","value":-102.1,"profit":false}]
Income After Taxes	-	37.75%	(33.14%)	(86.93%)	460.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":8.19,"profit":true},{"date":"2022-12-31","value":-7.19,"profit":false},{"date":"2023-12-31","value":-18.86,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	26.45%	(22.87%)	(85.54%)	460.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.74,"profit":true},{"date":"2022-12-31","value":-4.96,"profit":false},{"date":"2023-12-31","value":-18.56,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	26.45%	(22.87%)	(85.54%)	460.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.74,"profit":true},{"date":"2022-12-31","value":-4.96,"profit":false},{"date":"2023-12-31","value":-18.56,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(9.70%)	(23.49%)	(68.42%)	36.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-26.71,"profit":false},{"date":"2022-12-31","value":-64.7,"profit":false},{"date":"2023-12-31","value":-188.46,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	13.54M	11.87M	8.72M	10.00M	12.81M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":87.63,"profit":true},{"date":"2025-03-31","value":64.39,"profit":true},{"date":"2025-06-30","value":73.87,"profit":true},{"date":"2025-09-30","value":94.57,"profit":true}]
Cost of Revenue	4.44M	4.52M	3.65M	4.56M	4.51M	[{"date":"2024-09-30","value":97.28,"profit":true},{"date":"2024-12-31","value":99.1,"profit":true},{"date":"2025-03-31","value":80.07,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":98.79,"profit":true}]
Gross Profit	9.11M	7.35M	5.07M	5.44M	8.30M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":80.69,"profit":true},{"date":"2025-03-31","value":55.66,"profit":true},{"date":"2025-06-30","value":59.77,"profit":true},{"date":"2025-09-30","value":91.17,"profit":true}]
Gross Margin	67.24%	61.91%	58.12%	54.40%	64.82%	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":92.08,"profit":true},{"date":"2025-03-31","value":86.44,"profit":true},{"date":"2025-06-30","value":80.92,"profit":true},{"date":"2025-09-30","value":96.4,"profit":true}]

Operating Expenses	17.39M	20.93M	24.43M	16.81M	19.78M	[{"date":"2024-09-30","value":71.19,"profit":true},{"date":"2024-12-31","value":85.65,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":68.8,"profit":true},{"date":"2025-09-30","value":80.96,"profit":true}]
Operating Income	(8.29M)	(13.58M)	(19.36M)	(11.37M)	(11.48M)	[{"date":"2024-09-30","value":-829000000,"profit":false},{"date":"2024-12-31","value":-1357900000,"profit":false},{"date":"2025-03-31","value":-1936500000,"profit":false},{"date":"2025-06-30","value":-1136800000,"profit":false},{"date":"2025-09-30","value":-1147900000,"profit":false}]
Total Non-Operating Income/Expense	(6.44M)	(6.98M)	(7.13M)	(4.36M)	(7.93M)	[{"date":"2024-09-30","value":-643800000,"profit":false},{"date":"2024-12-31","value":-698000000,"profit":false},{"date":"2025-03-31","value":-713000000,"profit":false},{"date":"2025-06-30","value":-436000000,"profit":false},{"date":"2025-09-30","value":-793400000,"profit":false}]
Pre-Tax Income	(11.51M)	(17.07M)	(22.93M)	(13.55M)	(15.45M)	[{"date":"2024-09-30","value":-1150900000,"profit":false},{"date":"2024-12-31","value":-1706900000,"profit":false},{"date":"2025-03-31","value":-2293000000,"profit":false},{"date":"2025-06-30","value":-1354800000,"profit":false},{"date":"2025-09-30","value":-1544600000,"profit":false}]
Income Taxes	-	(14.00K)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1400000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	(17.05M)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1705500000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(11.51M)	(17.05M)	(22.93M)	(13.55M)	(15.45M)	[{"date":"2024-09-30","value":-1150900000,"profit":false},{"date":"2024-12-31","value":-1705500000,"profit":false},{"date":"2025-03-31","value":-2293000000,"profit":false},{"date":"2025-06-30","value":-1354800000,"profit":false},{"date":"2025-09-30","value":-1544600000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(11.51M)	(17.05M)	(22.93M)	(13.55M)	(15.45M)	[{"date":"2024-09-30","value":-1150900000,"profit":false},{"date":"2024-12-31","value":-1705500000,"profit":false},{"date":"2025-03-31","value":-2293000000,"profit":false},{"date":"2025-06-30","value":-1354800000,"profit":false},{"date":"2025-09-30","value":-1544600000,"profit":false}]

EPS (Diluted)	(0.13)	(0.16)	(0.22)	(0.14)	(0.11)	[{"date":"2024-09-30","value":-13,"profit":false},{"date":"2024-12-31","value":-16.07,"profit":false},{"date":"2025-03-31","value":-22.35,"profit":false},{"date":"2025-06-30","value":-14,"profit":false},{"date":"2025-09-30","value":-11.46,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(12.37%)	(26.52%)	14.71%	28.03%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-44.12,"profit":false},{"date":"2025-03-31","value":-94.6,"profit":false},{"date":"2025-06-30","value":52.49,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	-	1.87%	(19.20%)	24.89%	(1.21%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7.52,"profit":true},{"date":"2025-03-31","value":-77.15,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-4.84,"profit":false}]
Gross Profit	-	(19.31%)	(31.02%)	7.38%	52.54%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-36.75,"profit":false},{"date":"2025-03-31","value":-59.04,"profit":false},{"date":"2025-06-30","value":14.05,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	(7.92%)	(6.12%)	(6.39%)	19.14%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-41.37,"profit":false},{"date":"2025-03-31","value":-32,"profit":false},{"date":"2025-06-30","value":-33.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	-	20.30%	16.76%	(31.20%)	17.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":82.56,"profit":true},{"date":"2025-06-30","value":-153.7,"profit":false},{"date":"2025-09-30","value":87.04,"profit":true}]
Operating Income	-	63.80%	42.61%	(41.30%)	0.98%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":66.79,"profit":true},{"date":"2025-06-30","value":-64.73,"profit":false},{"date":"2025-09-30","value":1.53,"profit":true}]
Total Non-Operating Income/Expense	-	8.42%	2.15%	(38.85%)	81.97%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":10.27,"profit":true},{"date":"2025-03-31","value":2.62,"profit":true},{"date":"2025-06-30","value":-47.39,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	-	48.31%	34.34%	(40.92%)	14.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":71.08,"profit":true},{"date":"2025-06-30","value":-84.69,"profit":false},{"date":"2025-09-30","value":29,"profit":true}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	48.19%	34.45%	(40.92%)	14.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":71.48,"profit":true},{"date":"2025-06-30","value":-84.91,"profit":false},{"date":"2025-09-30","value":29.07,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	48.19%	34.45%	(40.92%)	14.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":71.48,"profit":true},{"date":"2025-06-30","value":-84.91,"profit":false},{"date":"2025-09-30","value":29.07,"profit":true}]

EPS (Diluted)	-	23.62%	39.08%	(37.36%)	(18.14%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":60.43,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-95.6,"profit":false},{"date":"2025-09-30","value":-46.43,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	44.63M	47.26M	39.89M	40.97M	88.22M	[{"date":"2020-12-31","value":50.58,"profit":true},{"date":"2021-12-31","value":53.57,"profit":true},{"date":"2022-12-31","value":45.21,"profit":true},{"date":"2023-12-31","value":46.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	18.26M	14.73M	17.18M	16.45M	13.20M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":80.69,"profit":true},{"date":"2022-12-31","value":94.1,"profit":true},{"date":"2023-12-31","value":90.1,"profit":true},{"date":"2024-12-31","value":72.32,"profit":true}]
Total Assets	62.88M	61.99M	57.07M	57.42M	101.42M	[{"date":"2020-12-31","value":62,"profit":true},{"date":"2021-12-31","value":61.12,"profit":true},{"date":"2022-12-31","value":56.27,"profit":true},{"date":"2023-12-31","value":56.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	21.10M	21.96M	39.53M	18.31M	18.86M	[{"date":"2020-12-31","value":53.39,"profit":true},{"date":"2021-12-31","value":55.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.32,"profit":true},{"date":"2024-12-31","value":47.73,"profit":true}]
Non-current Liabilities	90.28M	122.16M	136.10M	145.60M	142.72M	[{"date":"2020-12-31","value":62,"profit":true},{"date":"2021-12-31","value":83.9,"profit":true},{"date":"2022-12-31","value":93.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.02,"profit":true}]
Total Liabilities	111.38M	144.13M	175.62M	163.91M	161.58M	[{"date":"2020-12-31","value":63.42,"profit":true},{"date":"2021-12-31","value":82.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.33,"profit":true},{"date":"2024-12-31","value":92,"profit":true}]

Total Shareholders' equity
Common Stock	35.00K	41.00K	55.00K	69.00K	91.00K	[{"date":"2020-12-31","value":38.46,"profit":true},{"date":"2021-12-31","value":45.05,"profit":true},{"date":"2022-12-31","value":60.44,"profit":true},{"date":"2023-12-31","value":75.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(186.26M)	(256.80M)	(311.21M)	(319.08M)	(363.21M)	[{"date":"2020-12-31","value":-18625700000,"profit":false},{"date":"2021-12-31","value":-25679600000,"profit":false},{"date":"2022-12-31","value":-31120700000,"profit":false},{"date":"2023-12-31","value":-31907700000,"profit":false},{"date":"2024-12-31","value":-36321400000,"profit":false}]
Other Stockholders' Equity	137.72M	174.62M	192.60M	212.52M	302.97M	[{"date":"2020-12-31","value":45.46,"profit":true},{"date":"2021-12-31","value":57.64,"profit":true},{"date":"2022-12-31","value":63.57,"profit":true},{"date":"2023-12-31","value":70.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(48.50M)	(82.13M)	(118.55M)	(106.49M)	(60.16M)	[{"date":"2020-12-31","value":-4849700000,"profit":false},{"date":"2021-12-31","value":-8213400000,"profit":false},{"date":"2022-12-31","value":-11855400000,"profit":false},{"date":"2023-12-31","value":-10648700000,"profit":false},{"date":"2024-12-31","value":-6015600000,"profit":false}]

Total Liabilities & Shareholders Equity	62.88M	61.99M	57.07M	57.42M	101.42M	[{"date":"2020-12-31","value":62,"profit":true},{"date":"2021-12-31","value":61.12,"profit":true},{"date":"2022-12-31","value":56.27,"profit":true},{"date":"2023-12-31","value":56.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	5.90%	(15.60%)	2.70%	115.35%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.12,"profit":true},{"date":"2022-12-31","value":-13.52,"profit":false},{"date":"2023-12-31","value":2.34,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	(19.31%)	16.61%	(4.25%)	(19.74%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-116.2,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.57,"profit":false},{"date":"2024-12-31","value":-118.82,"profit":false}]
Total Assets	-	(1.42%)	(7.94%)	0.61%	76.64%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.85,"profit":false},{"date":"2022-12-31","value":-10.36,"profit":false},{"date":"2023-12-31","value":0.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	4.08%	79.97%	(53.68%)	3.04%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-67.13,"profit":false},{"date":"2024-12-31","value":3.8,"profit":true}]
Non-current Liabilities	-	35.32%	11.41%	6.98%	(1.98%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":32.29,"profit":true},{"date":"2023-12-31","value":19.77,"profit":true},{"date":"2024-12-31","value":-5.6,"profit":false}]
Total Liabilities	-	29.40%	21.85%	(6.67%)	(1.42%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.33,"profit":true},{"date":"2023-12-31","value":-22.7,"profit":false},{"date":"2024-12-31","value":-4.82,"profit":false}]

Total Shareholders' equity
Common Stock	-	17.14%	34.15%	25.45%	31.88%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":50.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":74.55,"profit":true},{"date":"2024-12-31","value":93.37,"profit":true}]
Retained Earnings	-	37.87%	21.19%	2.53%	13.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":55.95,"profit":true},{"date":"2023-12-31","value":6.68,"profit":true},{"date":"2024-12-31","value":36.53,"profit":true}]
Other Stockholders' Equity	-	26.79%	10.29%	10.34%	42.56%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":62.95,"profit":true},{"date":"2022-12-31","value":24.19,"profit":true},{"date":"2023-12-31","value":24.31,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	69.36%	44.34%	(10.18%)	(43.51%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.93,"profit":true},{"date":"2023-12-31","value":-14.68,"profit":false},{"date":"2024-12-31","value":-62.73,"profit":false}]

Total Liabilities & Shareholders Equity	-	(1.42%)	(7.94%)	0.61%	76.64%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.85,"profit":false},{"date":"2022-12-31","value":-10.36,"profit":false},{"date":"2023-12-31","value":0.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	96.57M	88.22M	89.17M	81.72M	151.67M	[{"date":"2024-09-30","value":63.67,"profit":true},{"date":"2024-12-31","value":58.16,"profit":true},{"date":"2025-03-31","value":58.79,"profit":true},{"date":"2025-06-30","value":53.88,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	13.39M	13.20M	13.06M	11.98M	11.89M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":98.63,"profit":true},{"date":"2025-03-31","value":97.59,"profit":true},{"date":"2025-06-30","value":89.46,"profit":true},{"date":"2025-09-30","value":88.78,"profit":true}]
Total Assets	109.96M	101.42M	102.23M	93.70M	163.56M	[{"date":"2024-09-30","value":67.23,"profit":true},{"date":"2024-12-31","value":62.01,"profit":true},{"date":"2025-03-31","value":62.51,"profit":true},{"date":"2025-06-30","value":57.29,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	15.15M	18.86M	18.30M	23.16M	25.57M	[{"date":"2024-09-30","value":59.25,"profit":true},{"date":"2024-12-31","value":73.77,"profit":true},{"date":"2025-03-31","value":71.55,"profit":true},{"date":"2025-06-30","value":90.54,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	140.23M	142.72M	144.87M	143.13M	142.09M	[{"date":"2024-09-30","value":96.8,"profit":true},{"date":"2024-12-31","value":98.52,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":98.8,"profit":true},{"date":"2025-09-30","value":98.09,"profit":true}]
Total Liabilities	155.38M	161.58M	163.16M	166.29M	167.67M	[{"date":"2024-09-30","value":92.67,"profit":true},{"date":"2024-12-31","value":96.37,"profit":true},{"date":"2025-03-31","value":97.31,"profit":true},{"date":"2025-06-30","value":99.18,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	91.00K	91.00K	99.00K	99.00K	121.00K	[{"date":"2024-09-30","value":75.21,"profit":true},{"date":"2024-12-31","value":75.21,"profit":true},{"date":"2025-03-31","value":81.82,"profit":true},{"date":"2025-06-30","value":81.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(346.16M)	(363.21M)	(386.14M)	(399.69M)	(415.14M)	[{"date":"2024-09-30","value":-34615900000,"profit":false},{"date":"2024-12-31","value":-36321400000,"profit":false},{"date":"2025-03-31","value":-38614400000,"profit":false},{"date":"2025-06-30","value":-39969200000,"profit":false},{"date":"2025-09-30","value":-41513800000,"profit":false}]
Other Stockholders' Equity	300.65M	302.97M	325.12M	327.00M	410.91M	[{"date":"2024-09-30","value":73.17,"profit":true},{"date":"2024-12-31","value":73.73,"profit":true},{"date":"2025-03-31","value":79.12,"profit":true},{"date":"2025-06-30","value":79.58,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(45.42M)	(60.16M)	(60.93M)	(72.59M)	(4.11M)	[{"date":"2024-09-30","value":-4542000000,"profit":false},{"date":"2024-12-31","value":-6015600000,"profit":false},{"date":"2025-03-31","value":-6093000000,"profit":false},{"date":"2025-06-30","value":-7259000000,"profit":false},{"date":"2025-09-30","value":-410900000,"profit":false}]

Total Liabilities & Shareholders Equity	109.96M	101.42M	102.23M	93.70M	163.56M	[{"date":"2024-09-30","value":67.23,"profit":true},{"date":"2024-12-31","value":62.01,"profit":true},{"date":"2025-03-31","value":62.51,"profit":true},{"date":"2025-06-30","value":57.29,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(8.65%)	1.08%	(8.35%)	85.60%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10.1,"profit":false},{"date":"2025-03-31","value":1.26,"profit":true},{"date":"2025-06-30","value":-9.76,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	(1.37%)	(1.05%)	(8.33%)	(0.76%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(7.76%)	0.80%	(8.35%)	74.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10.41,"profit":false},{"date":"2025-03-31","value":1.07,"profit":true},{"date":"2025-06-30","value":-11.2,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	24.51%	(3.01%)	26.54%	10.45%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":92.32,"profit":true},{"date":"2025-03-31","value":-11.32,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":39.36,"profit":true}]
Non-current Liabilities	-	1.77%	1.51%	(1.20%)	(0.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":84.91,"profit":true},{"date":"2025-06-30","value":-67.4,"profit":false},{"date":"2025-09-30","value":-40.9,"profit":false}]
Total Liabilities	-	3.99%	0.98%	1.91%	0.83%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":24.56,"profit":true},{"date":"2025-06-30","value":47.97,"profit":true},{"date":"2025-09-30","value":20.79,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	8.79%	-	22.22%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":39.56,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	4.93%	6.31%	3.51%	3.86%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":78.04,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":55.58,"profit":true},{"date":"2025-09-30","value":61.21,"profit":true}]
Other Stockholders' Equity	-	0.77%	7.31%	0.58%	25.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.01,"profit":true},{"date":"2025-03-31","value":28.49,"profit":true},{"date":"2025-06-30","value":2.26,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	32.44%	1.29%	19.14%	(94.34%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":3.97,"profit":true},{"date":"2025-06-30","value":58.98,"profit":true},{"date":"2025-09-30","value":-290.78,"profit":false}]

Total Liabilities & Shareholders Equity	-	(7.76%)	0.80%	(8.35%)	74.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10.41,"profit":false},{"date":"2025-03-31","value":1.07,"profit":true},{"date":"2025-06-30","value":-11.2,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(45.46M)	(32.98M)	(9.79M)	(6.38M)	(35.76M)	[{"date":"2020-12-31","value":-4545900000,"profit":false},{"date":"2021-12-31","value":-3297900000,"profit":false},{"date":"2022-12-31","value":-978900000,"profit":false},{"date":"2023-12-31","value":-638000000,"profit":false},{"date":"2024-12-31","value":-3575900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(517.00K)	(913.00K)	(2.52M)	(995.00K)	(159.00K)	[{"date":"2020-12-31","value":-51700000,"profit":false},{"date":"2021-12-31","value":-91300000,"profit":false},{"date":"2022-12-31","value":-252400000,"profit":false},{"date":"2023-12-31","value":-99500000,"profit":false},{"date":"2024-12-31","value":-15900000,"profit":false}]

Financing Activities
Net Financing Cash Flow	28.46M	30.11M	11.56M	3.97M	83.59M	[{"date":"2020-12-31","value":34.04,"profit":true},{"date":"2021-12-31","value":36.02,"profit":true},{"date":"2022-12-31","value":13.83,"profit":true},{"date":"2023-12-31","value":4.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	(17.52M)	(3.78M)	(751.00K)	(3.40M)	47.67M	[{"date":"2020-12-31","value":-36.75,"profit":false},{"date":"2021-12-31","value":-7.94,"profit":false},{"date":"2022-12-31","value":-1.58,"profit":false},{"date":"2023-12-31","value":-7.13,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(45.98M)	(33.89M)	(12.31M)	(7.38M)	(35.92M)	[{"date":"2020-12-31","value":-4597600000,"profit":false},{"date":"2021-12-31","value":-3389200000,"profit":false},{"date":"2022-12-31","value":-1231300000,"profit":false},{"date":"2023-12-31","value":-737500000,"profit":false},{"date":"2024-12-31","value":-3591800000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(27.45%)	(70.32%)	(34.82%)	460.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5.96,"profit":false},{"date":"2022-12-31","value":-15.27,"profit":false},{"date":"2023-12-31","value":-7.56,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	76.60%	176.45%	(60.58%)	(84.02%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":43.41,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-34.33,"profit":false},{"date":"2024-12-31","value":-47.62,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	5.81%	(61.60%)	(65.63%)	2003.47%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.29,"profit":true},{"date":"2022-12-31","value":-3.07,"profit":false},{"date":"2023-12-31","value":-3.28,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(78.41%)	(80.15%)	352.86%	(1501.76%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-22.22,"profit":false},{"date":"2022-12-31","value":-22.71,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-425.59,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(26.28%)	(63.67%)	(40.10%)	387.02%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-6.79,"profit":false},{"date":"2022-12-31","value":-16.45,"profit":false},{"date":"2023-12-31","value":-10.36,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(11.88M)	(6.49M)	(23.40M)	(7.91M)	(12.65M)	[{"date":"2024-09-30","value":-1188000000,"profit":false},{"date":"2024-12-31","value":-648900000,"profit":false},{"date":"2025-03-31","value":-2340000000,"profit":false},{"date":"2025-06-30","value":-791400000,"profit":false},{"date":"2025-09-30","value":-1264900000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(80.00K)	(15.00K)	(135.00K)	(107.00K)	(235.00K)	[{"date":"2024-09-30","value":-8000000,"profit":false},{"date":"2024-12-31","value":-1500000,"profit":false},{"date":"2025-03-31","value":-13500000,"profit":false},{"date":"2025-06-30","value":-10700000,"profit":false},{"date":"2025-09-30","value":-23500000,"profit":false}]

Financing Activities
Net Financing Cash Flow	(17.00K)	157.00K	20.65M	(100.00K)	81.41M	[{"date":"2024-09-30","value":-0.02,"profit":false},{"date":"2024-12-31","value":0.19,"profit":true},{"date":"2025-03-31","value":25.36,"profit":true},{"date":"2025-06-30","value":-0.12,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	(11.98M)	(6.35M)	(2.89M)	(8.12M)	68.53M	[{"date":"2024-09-30","value":-17.48,"profit":false},{"date":"2024-12-31","value":-9.26,"profit":false},{"date":"2025-03-31","value":-4.22,"profit":false},{"date":"2025-06-30","value":-11.85,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(11.96M)	(6.50M)	(23.54M)	(8.02M)	(12.88M)	[{"date":"2024-09-30","value":-1196000000,"profit":false},{"date":"2024-12-31","value":-650400000,"profit":false},{"date":"2025-03-31","value":-2353500000,"profit":false},{"date":"2025-06-30","value":-802100000,"profit":false},{"date":"2025-09-30","value":-1288400000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(45.38%)	260.61%	(66.18%)	59.83%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-17.41,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-25.39,"profit":false},{"date":"2025-09-30","value":22.96,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(81.25%)	800.00%	(20.74%)	119.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-10.16,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-2.59,"profit":false},{"date":"2025-09-30","value":14.95,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(1023.53%)	13050.32%	(100.48%)	(81511.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-7.84,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-0.77,"profit":false},{"date":"2025-09-30","value":-624.59,"profit":false}]

Net Change in Cash	-	(47.01%)	(54.48%)	181.10%	(943.82%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-25.96,"profit":false},{"date":"2025-03-31","value":-30.08,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-521.16,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(45.62%)	261.85%	(65.92%)	60.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-17.42,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-25.17,"profit":false},{"date":"2025-09-30","value":23.15,"profit":true}]

Aquestive Therapeutics Inc Ratios

Aquestive Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	AQST
Cash Ratio	5.05
Current Ratio	5.93
Quick Ratio	5.62

Aquestive Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	AQST
ROA (LTM)	-25.50%
ROE (LTM)	0.00%

Aquestive Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	AQST
Debt Ratio Lower is generally better. Negative is bad.	1.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.03

Aquestive Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	AQST
Trailing PE	NM
Forward PE	NM
P/S (TTM)	10.54
P/B	0.00
Price/FCF	NM
EV/R	8.52
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Aquestive Therapeutics Inc share price today?

Aquestive Therapeutics Inc (AQST) share price today is $3.65

Can Indians buy Aquestive Therapeutics Inc shares?

Yes, Indians can buy shares of Aquestive Therapeutics Inc (AQST) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AQST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aquestive Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Aquestive Therapeutics Inc (AQST) via the Vested app. You can start investing in Aquestive Therapeutics Inc (AQST) with a minimum investment of $1.

How to invest in Aquestive Therapeutics Inc shares from India?

You can invest in shares of Aquestive Therapeutics Inc (AQST) via Vested in three simple steps:

Click on Sign Up or Invest in AQST stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Aquestive Therapeutics Inc shares

What is Aquestive Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Aquestive Therapeutics Inc (AQST) is $7.55. The 52-week low price of Aquestive Therapeutics Inc (AQST) is $2.12.

What is Aquestive Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aquestive Therapeutics Inc (AQST) is

What is Aquestive Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aquestive Therapeutics Inc (AQST) is 0.00

What is Aquestive Therapeutics Inc dividend yield?

The dividend yield of Aquestive Therapeutics Inc (AQST) is 0.00%

What is the Market Cap of Aquestive Therapeutics Inc?

The market capitalization of Aquestive Therapeutics Inc (AQST) is $457.51M

What is Aquestive Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Aquestive Therapeutics Inc is AQST

How Can Investors Use Aquestive Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Aquestive Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Aquestive Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Aquestive Therapeutics Inc shares for Indian investors?

When investing in Aquestive Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Aquestive Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Aquestive Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Aquestive Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Aquestive Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Aquestive Therapeutics Inc Share Price

Aquestive Therapeutics Inc Analyst Forecast

Aquestive Therapeutics Inc Share Price Chart

Aquestive Therapeutics Inc Key Stock Metrics

About Aquestive Therapeutics Inc, Common Stock

Aquestive Therapeutics Inc Stock Returns

Aquestive Therapeutics Inc Financials

Aquestive Therapeutics Inc Ratios

Aquestive Therapeutics Inc Liquidity Ratios

Aquestive Therapeutics Inc Asset Efficiency Ratios

Aquestive Therapeutics Inc Liability Ratios

Aquestive Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Aquestive Therapeutics Inc Share Price

Aquestive Therapeutics Inc Analyst Forecast

Aquestive Therapeutics Inc Share Price Chart

Aquestive Therapeutics Inc Key Stock Metrics

About Aquestive Therapeutics Inc, Common Stock

Aquestive Therapeutics Inc Stock Returns

Aquestive Therapeutics Inc Financials

Aquestive Therapeutics Inc Ratios

Aquestive Therapeutics Inc Liquidity Ratios

Aquestive Therapeutics Inc Asset Efficiency Ratios

Aquestive Therapeutics Inc Liability Ratios

Aquestive Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²